The Medical Letter on Drugs and Therapeutics
FROM
ISSUE926
ISSUE926
July 8, 1994
Intranasa Budesonide for Allergic Rhinitis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Intranasa Budesonide for Allergic Rhinitis
July 8, 1994 (Issue: 926)
An intranasal formulation of the corticosteroid budesonide (Rhinocort Nasal Inhaler - Astra) was recently approved by the US Food and Drug Administration for treatment of seasonal or perennial allergic rhinitis in adults and children and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.